Where does Klemm + Sohn GMBH & Co. KG rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Klemm + Sohn GMBH & Co. KG ranks #1,297 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Klemm + Sohn GMBH & Co. KG hold?

Klemm + Sohn GMBH & Co. KG holds 326 US utility patents granted between 2015 and 2025, spanning 4 technology areas.

What is Klemm + Sohn GMBH & Co. KG's Innovation Score?

Klemm + Sohn GMBH & Co. KG has an Innovation Score of 33.0 out of 100 (43rd percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Klemm + Sohn GMBH & Co. KG's patent grant rate increasing or decreasing?

Klemm + Sohn GMBH & Co. KG's recent grant velocity is -27% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Klemm + Sohn GMBH & Co. KG's patents?

Klemm + Sohn GMBH & Co. KG's patents average 1.8 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Klemm + Sohn GMBH & Co. KG patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Klemm + Sohn GMBH & Co. KG

Q: What technology areas does Klemm + Sohn GMBH & Co. KG focus on?

Klemm + Sohn GMBH & Co. KG's top technology area is A01H (NEW Plants OR ; NON-TRANSGENIC; Processes FOR Obtaining THEM; Plant Reproduction BY Tissue Culture Techniques) with 13 patents, ranking #54 of 285 assignees active in that subclass. Grants appear in 4 CPC subclasses total.

USPTO PatentsView assignee record - 326 granted patents across 4 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A01H (NEW Plants OR ; NON-TRANSGENIC; Processes FOR Obtaining THEM; Plant Reproduction BY Tissue Culture Techniques).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Klemm ranks #1,297 of 49,997 tracked US assignees by granted-patent volume, with 326 patents across 4 technology areas.

#1,297
of 49,997 US assignees by volume: 43rd percentile
by Innovation Score (33.0/100): 1.8
avg claims per patent: -27%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R1297 · Foreign Corporation #1,297 · 326 grants

GRANTS-MID · TOP-DECILE · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-SPARSE · TYPE-FRNCORP · VEL-DOWN · BOOK-FULL

GRANTS-MID 326 grants
TOP-DECILE #1,297/49,997
PHOTO-FINISH Bayer Pharma…
CPC-NARROW A01H · 4 areas
INNOV-THIN 33.0/100
CLAIMS-SPARSE 1.8 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-DOWN -27% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Bayer Pharma Aktiengesellschaft (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Klemm’s 33.0 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 20.0 pts (61%) Velocity 4.8 pts (15%) Breadth 7.1 pts (22%) Claim depth 1.1 pts (3%)

Qualcomm Incorporated · highest

85
Guangdong Gopod… · near

33
Ballet Global · near

33
Klemm + Sohn & KG · this assignee

33
Pricer AB · near

33
CorMatrix Cardiovasc… · near

33
3D Lighting… · lowest

7

What this shows Klemm's Innovation Score is 33.0/100 (43rd percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Klemm?

Each dot is one of Klemm’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Klemm’s own 1.8 claims/patent is at or below the 14.4 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Klemm vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Klemm's grants concentrate

Klemm + Sohn GMBH & Co. KG is a focused PatentsView assignee: 4 CPC subclasses with 4% of grants classified under A01H (NEW Plants OR ; NON-TRANSGENIC; Processes FOR Obtaining THEM; Plant Reproduction BY Tissue Culture Techniques). Peak complete grant year is 2019 (45 grants) versus a trough of 14 in 2023. By volume, Klemm sits between MedImmune Limited and Sumitomo Riko Company Limited.

Klemm's three-year grant acceleration

From 2019–2021 to 2022–2024, Klemm + Sohn GMBH & Co. KG moved from 102 to 74 grants (0.72x the prior three-year total, a multiple, not a CAGR). Among 3,296 tracked assignees with ≥100 grants and ≥20 prior-period grants, that multiple ranks #2,071. See the growth leaderboard.

Medimmune

327
University of Hou…

327
Bayer Pharma Akti…

326
Hangzhou Hikvisio…

326
Littelfuse

326
Ningde Amperex Te…

326
Sick

326
Sumitomo Riko

326
Klemm + Sohn & KG ◀

326

What this shows Klemm holds 326 patents at rank #1,297, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Klemm

By rank, the assignees closest to #1,297 in granted patent volume.

Leaders in A01H (NEW Plants OR)

Other assignees with the most granted patents in Klemm's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Klemm, neither rank-band nor same-CPC leaders (those blocks stay above). In A01H (NEW Plants OR), Klemm ranks #54 of 285 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (33 here).

Pricer AB 33 Ballet Global Inc. 33 CorMatrix Cardiovascular, Inc. 33 Guangdong Gopod Group Holding Co., Ltd. 33

Similar claim depth

Nearest assignees by average claims per patent (1.8 here).

Tenacious Holdings, Inc. 1.8 avg Skechers U.S.A., Inc. II 1.8 avg Iris Ohyama Inc. 1.8 avg Richemont International SA 1.8 avg

Klemm's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

33 43rd percentile higher than 43% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Klemm + Sohn GMBH & Co. KG patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	25	7.7%
2016	44	13.5%
2017	40	12.3%
2018	25	7.7%
2019	45	13.8%
2020	24	7.4%
2021	33	10.1%
2022	40	12.3%
2023	14	4.3%
2024	20	6.1%
2025partial year	16	4.9%

Which technologies does Klemm + Sohn GMBH & Co. KG patent most?

A01H - NEW Plants OR ; NON-TRANSGENIC; Processes FOR Obtaining THEM; Plant Reproduction BY Tissue Culture Techniques 13

C12Q - Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Microbiological OR Enzymological Processes 3

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 1

C12Y - Enzymes 1

Top 4 of 4 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Klemm + Sohn GMBH & Co. KG's patent record in context - here's where to go next.

Klemm + Sohn GMBH & Co. KG's lead technology class is A01H (NEW Plants OR ; NON-TRANSGENIC; Processes FOR Obtaining THEM; Plant Reproduction BY Tissue Culture Techniques), 4% of its portfolio - see every assignee active in that class. Explore A01H
Ranked #1,297 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Klemm + Sohn GMBH & Co. KG against MedImmune Limited, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 33.0/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent , US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.